|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: dofetilide
Summary for Generic Name: dofetilide
| |||||||||||||||
Clinical Trials for: dofetilideHigh Intensity Focused Ultrasound (HIFU) Ablation System Study Status: Suspended Condition: Atrial Fibrillation A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation Status: Completed Condition: Atrial Fibrillation A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation Status: Completed Condition: Paroxysmal Atrial Fibrillation Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation Status: Recruiting Condition: Atrial Fibrillation AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study Status: Terminated Condition: Atrial Fibrillation; Heart Failure Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia Status: Terminated Condition: Defibrillators, Implantable; Tachycardia, Ventricular Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Status: Completed Condition: Atrial Fibrillation; Arrhythmia Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Status: Recruiting Condition: Atrial Fibrillation; Arrhythmia Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | TIKOSYN | dofetilide | CAPSULE; ORAL | 020931 | Oct 1, 1999 | RX | Yes | 4,959,366 | Y | Y | <disabled> | TREATMENT OF CARDIAC ARRHYTHMIA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer | TIKOSYN | dofetilide | CAPSULE; ORAL | 020931 | Oct 1, 1999 | RX | Yes | 6,124,363 | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer | TIKOSYN | dofetilide | CAPSULE; ORAL | 020931 | Oct 1, 1999 | RX | No | 6,124,363 | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer | TIKOSYN | dofetilide | CAPSULE; ORAL | 020931 | Oct 1, 1999 | RX | No | 4,959,366 | Y | Y | <disabled> | TREATMENT OF CARDIAC ARRHYTHMIA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc